Want to join the conversation?
$LH's largest contributing segment LabCorp Diagnostics 4Q15 revenue rose 4.3% to $1.55Bil vs. 4Q14, helped by an increase in net revenue due to organic volume growth, Beacon LBS, price, mix & tuck-in acquisitions, partially offset by currency. Covance Drug Development revenue rose 4.7% to $691.4MM vs. 4Q14, due to negative impact of the US dollar.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.